Dual action, inhaled formulations providing both an...

Details Dual action, inhaled formulations providing both an... Dual action, inhaled formulations providing both an...

2008-10-30

2011-12-06

Long, Scott (Department: 1633)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

C424S043000, C514S253080

Reexamination Certificate

active

08071127

ABSTRACT:
Methods for formulating immediate and sustained release anti-infectives and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.

REFERENCES:
patent: 5006343 (1991-04-01), Benson et al.
patent: 5401511 (1995-03-01), Margalit
patent: 5823178 (1998-10-01), Lloyd et al.
patent: 6197333 (2001-03-01), Onyuksel et al.
patent: 6221385 (2001-04-01), Camu et al.
patent: 6316024 (2001-11-01), Allen et al.
patent: 6355267 (2002-03-01), Collins
patent: 6534018 (2003-03-01), Baker et al.
patent: 6623671 (2003-09-01), Coe et al.
patent: 6759057 (2004-07-01), Weiner et al.
patent: 6770291 (2004-08-01), Smyth-Templeton et al.
patent: 6855296 (2005-02-01), Baker et al.
patent: 6890555 (2005-05-01), Desai et al.
patent: 2003/0224039 (2003-12-01), Boni et al.
patent: 2004/0009126 (2004-01-01), Pilkiewicz et al.
patent: 2004/0142026 (2004-07-01), Boni et al.
patent: 2006/0073198 (2006-04-01), Boni et al.
patent: 2007/0077290 (2007-04-01), Li et al.
patent: 2007/0196461 (2007-08-01), Weers
patent: 2009/0274754 (2009-11-01), Cipolla et al.
patent: 2101241 (1993-07-01), None
patent: 2215716 (1997-09-01), None
patent: 2174803 (1997-10-01), None
patent: 1083881 (2001-03-01), None
patent: 1083886 (2003-04-01), None
patent: 99/51202 (1999-10-01), None
Desai et al (Journal of Controlled Release. 2002; 84: 69-78).
Desai et al. (Journal of Pharmaceutical Sciences. 2002; 91(2): 482-491).
Wong et al (Journal of Controlled Release. 2003; 92: 265-273).
Conley et al (Antimicrobial Agents and Chemotherapy. 1997; 41(6): 1288-1292).
Lipuma JJ., Microbiological and immunologic considerations with aerosolized drug delivery. Chest. Sep. 2001;120(3 Suppl):118S-123S .
Moss RB., Administration of aerosolized antibiotics in cystic fibrosis patients. Chest. Sep. 2001;120(3 Suppl):107S-113S.
Smith Al, et al. Safety of aerosol tobramycin administration for 3 months to patients with cystic fibrosis. Ped Pulmonol. 1989;7(4):265-271.
Van Heeckeren Am, et al. Role of Cftr genotype in the response to chronicPseudomonas aeruginosalung infection in mice. Am J Physiol Lung Cell Mol Physiol. Nov. 2004;287(5):L944-52. Epub Jul. 9, 2004.
Van Heeckeren Am, et al.. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronicPseudomonas aeruginosalung infection. Am J Physiol Lung Cell Mol Physiol. Apr. 2004;286(4):L717-26. Epub Sep. 26, 2003.
Van Heeckeren A, et al.., Effects of bronchopulmonary inflammation induced byPseudomonas aeruginosaon adenovirus-mediated gene transfer to airway epithelial cells in mice. Gene Ther. Mar. 1998;5(3):345-51.
Van Heeckeren Am, et al., Murine models of chronicPseudomonas aeruginosalung infection. Lab Anim. Jul. 2002;36(3):291-312.
Van Heeckeren Am, et al., Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice. Am J Respir Crit Care Med. Jan. 2000;161(1):271.
Weber A, et al., Nebulizer delivery of tobramycin to the lower respiratory tract. Pediatr Pulmonol. May 1994;17(5):331-9.
Bangham et al., “Diffusion of Univalent Ions across the Lamellae of Swollen Phospholipids” J. Mol. Biol., 13:238-252 (1965).

Affiliated with

Also associated with

Rating

Dual action, inhaled formulations providing both an... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dual action, inhaled formulations providing both an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dual action, inhaled formulations providing both an... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4314291